|
|
|
|
Vol. 59, Issue 4, 758-764, April 2001
-Arrestins with the
Intracellular Domains of Different Opioid Receptors
Shanghai Institute of Cell Biology, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences,
Shanghai (B.C., Y.X., G.P.); and National Laboratory of Medical
Neurobiology, Medical Center of Fudan University, Shanghai, People's
Republic of China (L.M.)
-arrestins have been shown to play important roles in regulation of
signaling and desensitization of opioid receptors in many in vivo
studies. The current study was carried out to measure the direct
interaction of
-arrestins with two functional intracellular domains,
the third intracellular loop (I3L) and the carboxyl terminus (CT), of
-, µ-, and
-opioid receptors (DOR, MOR, and KOR, respectively). Results from the pull-down assay using glutathione
S-transferase fusion proteins demonstrated that
-arrestins (1 and 2) were able to bind to the I3L of DOR and to the
CT of DOR and KOR. Surface plasmon resonance measurement gave similar
results with typical dissociation equilibrium constant
(KD) values in the micromolar range. The
site-directed mutagenesis experiment further revealed that certain
specific serine/threonine residues in these receptor domains play a
critical role in their interaction with
-arrestins. Taken together,
our data clearly indicated that
-arrestins interact differentially
with the functional domains of different opioid receptors; this may
provide a possible molecular basis for differential regulation of
opioid receptors by
-arrestins.
This article has been cited by other articles:
![]() |
H. Lan, M. M. Teeter, V. V. Gurevich, and K. A. Neve An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors Mol. Pharmacol., January 1, 2009; 75(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lan, Y. Liu, M. I. Bell, V. V. Gurevich, and K. A. Neve A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding Mol. Pharmacol., January 1, 2009; 75(1): 113 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Krasel, U. Zabel, K. Lorenz, S. Reiner, S. Al-Sabah, and M. J. Lohse Dual Role of the {beta}2-Adrenergic Receptor C Terminus for the Binding of {beta}-Arrestin and Receptor Internalization J. Biol. Chem., November 14, 2008; 283(46): 31840 - 31848. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Peverelli, G. Mantovani, D. Calebiro, A. Doni, S. Bondioni, A. Lania, P. Beck-Peccoz, and A. Spada The Third Intracellular Loop of the Human Somatostatin Receptor 5 Is Crucial for Arrestin Binding and Receptor Internalization after Somatostatin Stimulation Mol. Endocrinol., March 1, 2008; 22(3): 676 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qiu, H. H. Loh, and P.-Y. Law Phosphorylation of the {delta}-Opioid Receptor Regulates Its beta-Arrestins Selectivity and Subsequent Receptor Internalization and Adenylyl Cyclase Desensitization J. Biol. Chem., August 3, 2007; 282(31): 22315 - 22323. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Walwyn, C. J. Evans, and T. G. Hales {beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons J. Neurosci., May 9, 2007; 27(19): 5092 - 5104. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Quack, L. C. Rump, P. Gerke, I. Walther, T. Vinke, O. Vonend, T. Grunwald, and L. Sellin beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity PNAS, September 19, 2006; 103(38): 14110 - 14115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ross, J. Riley, C. Quigley, and K. I. Welsh Clinical Pharmacology and Pharmacotherapy of Opioid Switching in Cancer Patients Oncologist, July 1, 2006; 11(7): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Morou and Z. Georgoussi Expression of the Third Intracellular Loop of the {delta}-Opioid Receptor Inhibits Signaling by Opioid Receptors and Other G Protein-Coupled Receptors J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1368 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heydorn, B. P. Sondergaard, B. Ersboll, B. Holst, F. C. Nielsen, C. R. Haft, J. Whistler, and T. W. Schwartz A Library of 7TM Receptor C-terminal Tails: INTERACTIONS WITH THE PROPOSED POST-ENDOCYTIC SORTING PROTEINS ERM-BINDING PHOSPHOPROTEIN 50 (EBP50), N-ETHYLMALEIMIDE-SENSITIVE FACTOR (NSF), SORTING NEXIN 1 (SNX1), AND G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN (GASP) J. Biol. Chem., December 24, 2004; 279(52): 54291 - 54303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Macey, V. V. Gurevich, and K. A. Neve Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons Mol. Pharmacol., December 1, 2004; 66(6): 1635 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, S. Ahn, W. G. Barnes, and R. J. Lefkowitz Stable Interaction between {beta}-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for {beta}-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2 J. Biol. Chem., November 12, 2004; 279(46): 48255 - 48261. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, H. H. Loh, and P.-Y. Law The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells J. Biol. Chem., September 19, 2003; 278(38): 36848 - 36858. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, H. Gao, Y. Ni, B. Wang, Y. Wu, L. Ji, L. Qin, L. Ma, and G. Pei beta -Arrestin 2 Functions as a G-Protein-coupled Receptor-activated Regulator of Oncoprotein Mdm2 J. Biol. Chem., February 14, 2003; 278(8): 6363 - 6370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roland, B. J. Murphy, B. Ahr, V. Robert-Hebmann, V. Delauzun, K. E. Nye, C. Devaux, and M. Biard-Piechaczyk Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling Blood, January 15, 2003; 101(2): 399 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castro, F. Dicker, J.-P. Vilardaga, C. Krasel, M. Bernhardt, and M. J. Lohse Dual Regulation of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Signaling by Protein Kinase C and {beta}-Arrestins Endocrinology, October 1, 2002; 143(10): 3854 - 3865. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huttenrauch, A. Nitzki, F.-T. Lin, S. Honing, and M. Oppermann beta -Arrestin Binding to CC Chemokine Receptor 5 Requires Multiple C-terminal Receptor Phosphorylation Sites and Involves a Conserved Asp-Arg-Tyr Sequence Motif J. Biol. Chem., August 16, 2002; 277(34): 30769 - 30777. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kishi, H. Krishnamurthy, C. Galet, R. S. Bhaskaran, and M. Ascoli Identification of a Short Linear Sequence Present in the C-terminal Tail of the Rat Follitropin Receptor That Modulates Arrestin-3 Binding in a Phosphorylation-independent Fashion J. Biol. Chem., June 7, 2002; 277(24): 21939 - 21946. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Lowe, J. P. Celver, V. V. Gurevich, and C. Chavkin {micro}-Opioid Receptors Desensitize Less Rapidly than delta -Opioid Receptors Due to Less Efficient Activation of Arrestin J. Biol. Chem., May 3, 2002; 277(18): 15729 - 15735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, J.-G. Li, C. Chen, F. Zhang, and L.-Y. Liu-Chen Molecular Basis of Differences in (-)(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-Induced Desensitization and Phosphorylation between Human and Rat kappa -Opioid Receptors Expressed in Chinese Hamster Ovary Cells Mol. Pharmacol., January 1, 2002; 61(1): 73 - 84. [Abstract] [Full Text] [PDF] |
||||